Increased plasma adiponectin following pioglitazone treatment for two weeks has been reported to be associated with improved insulin resistance and diabetes in ob/ob mice, but not in APN-KO/ob/ob mice32. The gene discussed is ADIPOQ; the disease is diabetes mellitus.